LBIO is the perfect comparison to have a fine understanding on how Mr. Cataldo operates and his capabilities. So many CEO's for the OTC stocks say they are going to uplist, and they are going to do this, or that. This is why it is crucial to do your DD and invest in the CEO behind the company and his or her team. Where did they come from and what did they accomplish. Genesis Biopharma, now Lion Biotechnologies, grew from a penny stock with a 2MM market cap to 250MM market cap. The team of doctors that has joined OXIS are second to none. They have proven their work with US patents, they are special government employees and work for the FDA. To have someone who works for the FDA on your team to oversee the trial phases for FDA approval is mostly unheard of. Then to recently announce the addition of highly respected Dr Yee, who has a most impressive resume the size of Texas, just screams for a large investment coming very soon.
From an investor mindset, besides the Cancer Immunotherapy Index taking off, the marijuana sector is the largest growing industry. When you put the two together, you are sitting on an explosive reaction.
News 
Market Data 
Discover 
AI
